
On Veterans Day, we honor the courage and sacrifice of the men and women who have served in the U.S. Armed Forces. We're grateful for your service and for the example you set in our communities every day. #VeteransDay #MenariniStemline

Stemline, a subsidiary of the Menarini Group, is focused on bringing transformational oncology treatments to those living with cancer. bit.ly/48X6JSN

On Veterans Day, we honor the courage and sacrifice of the men and women who have served in the U.S. Armed Forces. We're grateful for your service and for the example you set in our communities every day. #VeteransDay #MenariniStemline

On National STEM Day, we celebrate the scientists, engineers, and innovators whose curiosity drives medicine forward. At Menarini Stemline, we're proud to support colleagues across STEM fields who help turn discovery into meaningful treatments for patients. #NationalSTEMDay #MenariniStemline

Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study in Heavily Pretreated Relapsed/Refractory B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting. Read today’s press release here: menarini.com/en-us/news/news… #MenariniStemline #ASH2026

This National Family Caregivers Month, we're honoring the caregivers who bring that same spirit to life every day. They support loved ones with strength, patience, and compassion through a cancer diagnosis. Thank you for all that you do. #NationalFamilyCaregiversMonth #MenariniStemline

Breast Cancer Awareness Month may be coming to a close, but our commitment doesn’t end here. We’ll continue to shine a light on breast cancer and work toward better outcomes for the community, all year long. Thank you for being part of the conversation this October. #BreastCancerAwarenessMonth #BreastCancer #mBCAwareness #Oncology #MenariniStemline

Our team is back from the ESMO Congress 2026! We’ve returned from Madrid with new insights and are energized after connecting with so many professionals who are dedicated to improving patient outcomes. #ESMO26 #ESMO #MenariniStemline

Georgiamune and Menarini Group enter exclusive global license and collaboration agreement for a first-in-class oral immuno-oncology agent. Read today’s press release here: stemline.com/news-and-media/ hashtag#MenariniStemline

Our team had a wonderful few days at JADPRO Live 2026 in Minneapolis, connecting with the advanced practitioner community. We’re returning inspired and motivated as we continue advancing our mission to transform patient care. Thank you to everyone who stopped by! #JADPRO #JADPROLive #MenariniStemline

The Menarini Stemline team is looking forward to the ESMO Congress 2026 in Madrid. We’re excited to be a part of the global oncology discussions that are shaping the future of cancer care. If you’re attending, we’d love to connect. See you in Madrid! #ESMO26 #ESMO #MenariniStemline

Breast cancer can affect anyone. This Men's Breast Cancer Awareness Week, we're focused on a group that is too often left out of the conversation. Because male breast cancer accounts for less than 1% of all breast cancer diagnoses, early signs can be overlooked or dismissed, sometimes leading to a later diagnosis. Awareness helps encourage men to know the signs, speak up, and seek care early. #BreastCancerAwarenessMonth #MensBreastCancerAwareness #BreastCancer #Oncology #MenariniStemline

Members of the Menarini Stemline team were thrilled to attend Lymphoma, Leukemia & Myeloma Congress in NYC. From deep dives into emerging clinical research to connecting with fellow leaders across leukemia, lymphoma, and myeloma, collaborative moments like these reinforce our commitment to advancing hematology research and addressing unmet needs for patients. #Oncology #MenariniStemline

The Menarini Stemline team was pleased to join the hematology and oncology community at the DGHO Annual Meeting in Vienna. It was a valuable few days of scientific exchange and connection with colleagues advancing care for patients with blood cancers and other malignancies across Europe and beyond. #DGHO2026 #MenariniStemline

On #MetastaticBreastCancerAwarenessDay, we're reflecting on our ongoing commitment to the mBC community. Over the past year, we asked our colleagues one question: "What are your three wishes for the mBC community?" Their answers are a reminder that patients are at the heart of everything we do, today and every day. #BreastCancerAwarenessMonth #BreastCancer #mBCAwareness #Oncology #MenariniStemline

The Menarini Stemline team is heading to Minneapolis for JADPRO Live 2026! We’re looking forward to connecting with the advanced practitioner community and sharing our commitment to evolving cancer care. If you’re onsite at #JADPROLive, come find us at our booth. #JADPRO #MenariniStemline

No two breast cancers are exactly alike. What looks like one disease is actually several, and the differences matter, because they shape how each person is treated. Knowing the subtype is a crucial part of getting appropriate care that is tailored to an individual diagnosis. #BreastCancerAwarenessMonth #BreastCancer #mBCAwareness #Oncology #MenariniStemlin

What an inspiring start to Breast Cancer Awareness Month! Our team recently connected with patient advocates and community leaders at the Living Beyond Breast Cancer (LBBC) Fall Summit and the Sisters Network Black Breast Cancer Summit. We’re grateful for the conversations, the connections, and a shared commitment to supporting everyone affected by breast cancer. #BreastCancerAwarenessMonth #BreastCancer #Oncology #MenariniStemline